IDiyas

For the Inventor, By the Inventor

Lyons, France

Guillaume Monneret

USPTO Granted Patents = 14


Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal13 out of 637 
 
Biomerieux, Inc.
 patents
silverMedal10 out of 42 
 
Hospices Civils De Lyon
 patents
bronzeMedal2 out of 2 
 
Hospices Civils De Lyon (hcl)
 patents
4. 1 out of 10 
 
Université Claude Bernard
 patents
5. 1 out of 208 
 
Universite Claude Bernard – Lyon1
 patents
6. 1 out of 23 
 
Centre Hospitalier Universitaire De Nantes
 patents
7. 1 out of 49 
 
Université Claude Bernard Lyon I
 patents
8. 1 out of 5,069 
 
Centre National De La Recherche Scientifique
 patents
where one patent can have more than one assignee

Years Active: 2015-2024

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 12110556 - Kit for assessing the risk of complications in patients with systemic inflammatory response syndrome (SIRS) (2024-10-08),
2. 11821038 - Method for diagnosis and/or prognosis of a septic syndrome (2023-11-21),
3. 11377690 - Method and kit for making an in vitro prognosis of severity for a patient in septic shock (2022-07-05),
4. 11339438 - Method for assessing the risk of complications in patients with systemic inflammatory response syndrome (sirs) (2022-05-24),
5. 11299768 - Methods for determining a patient's susceptibility of contracting a nosocomial infection and for establishing a prognosis of the progression of septic syndrome (2022-04-12),
6. 11180806 - Process and kit for determining in vitro the immune status of an individual (2021-11-23),
7. 11060143 - Method for diagnosis and/or prognosis of a septic syndrome (2021-07-13),
8. 10725029 - Kit for in vitro or ex vivo measurement of SCD127 expression in a biological sample (2020-07-28),
9. 10663472 - Method for evaluating the risk of mortality in patients who exhibit a systemic inflammatory response syndrome (SIRS) or sepsis (2020-05-26),
10. 10466255 - Prediction of the risk of developing a disseminated infection for patients admitted to an intensive care unit (2019-11-05),
11. 9982298 - Process and kit for determining in vitro the immune status of an individual (2018-05-29),
12. 9896415 - Chalcone derivatives having an anti-allergic activity (2018-02-20),
13. 9823239 - Process for determining the susceptibility to nosocomial infections (2017-11-21),
14. 9110079 - Method and kit for establishing an in vitro prognosis on a patient exhibiting SIRS (2015-08-18),

Title: Guillaume Monneret - Pioneering French Inventor

Introduction:

Guillaume Monneret is a distinguished inventor hailing from Lyons, France, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Guillaume Monneret holds several patents in various technological domains, including advancements in renewable energy, artificial intelligence, and sustainable transportation.

Career Highlights:

Throughout his illustrious career, Guillaume Monneret has been at the forefront of technological innovation, leading research and development projects that have revolutionized industries and improved the quality of life for many.

Collaborations:

Guillaume Monneret has collaborated with leading research institutions, universities, and innovative companies to bring his ideas to life and turn them into tangible solutions that benefit society as a whole.

Conclusion:

In conclusion, Guillaume Monneret's dedication to pushing the boundaries of innovation and his relentless pursuit of technological advancement have solidified his reputation as a visionary inventor with a lasting impact on the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…